BusinessScienceTop Stories

Drug Delivery Devices Market Size, Opportunities Analysis With BD, 3M, Crossject, Sanofi, Pfizer, Novartis, Bayer, Alkermes, Merck And More

Global drug delivery devices market is expected to rise from its initial estimated value of USD 1243.34 billion in 2018 to a projected value of USD 2070.12 billion by 2026, registering a CAGR of 6.58% in the forecast period of 2019-2026. This rise in market value can be attributed to the constant innovations and advancements in the market resulting in product launches (Current Year Updated Statistic Will Be Provided in Report).

 Get Free Sample of This Market Information:

 Market Definition: Global Drug Delivery Devices Market

Drug delivery devices are those medical devices and equipments that are used for dispatching the drugs into the human bodies and various systems. They are specifically made for dispatching the specific drugs according to the various administration techniques. These devices are used for the therapeutic treatments and entire recovery procedure.

Market Drivers:

  • Increasing prevalence of chronic diseases globally resulting in increased consumption of therapeutic drugs and therapies; this factor is expected to act as a driver for the market growth
  • Growth in the consumption of drugs and therapeutic pharmaceuticals because of the development and better nature of treatment associated with these drugs; this factor is expected to act as a driver for the market growth

Market Restraint:

  • Increase in complications and expertise required in delivering therapeutics and drugs through these devices; this factor is expected to act as a restraint to the market growth

 Key Market Competitors: Global Drug Delivery Devices Market

BD.; F. Hoffmann-La Roche Ltd; Antares Pharma; Novartis AG; 3M; Sulzer Ltd; Gerresheimer AG; Sanofi; Johnson & Johnson Services, Inc.; Bayer AG; GlaxoSmithKline plc; Novosanis; MEDMIX SYSTEMS AG; Merck & Co., Inc.; Pfizer Inc.; Insulet Corporation; OraSure Technologies, Inc.; Enable Injections; West Pharmaceutical Services, Inc.; SMC Ltd.; ViVO Smart Medical Devices Ltd. and Cipla Inc. are few of the major competitors currently present in the market.

Get TOC For Full Analysis Of Report:

Global drug delivery devices market is highly fragmented and the major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes market shares of drug delivery devices market for global, Europe, North America, Asia-Pacific, South America and Middle East & Africa.

Segmentation: Global Drug Delivery Devices Market

  • By Route of Administration
    • Oral Drug Delivery
  • Solid Oral Drugs
  • Tablets
  • Capsules
  • Powders
  • Pills
  • Liquid Oral Drugs
  • Syrups
  • Solutions
  • Semi-Solid Oral Drugs
  • Gels
  • Emulsions
  • Elixirs
    • Injectable Drug Delivery
  • Conventional Injection Devices (By Material)
  • Glass
  • Plastic
  • Conventional Injection Devices (By Product)
  • Fillable Syringes
  • Pre-Filled Syringes
  • Conventional Injection Devices (By Usability)
  • Reusable Syringes
  • Disposable Syringes
  • Self-Injection Devices
  • Needle-Free Injectors
  • Autoinjectors
  • Pen Injectors
  • Wearable Injectors
  • Other Injector Devices
    • Topical Drug Delivery
  • Liquid Formulations
  • Solutions
  • Suspensions
  • Semi-Solid Formulations
  • Creams
  • Gels
  • Ointments
  • Pastes
  • Lotions
  • Solid Formulations
  • Suppositories
  • Powders
  • Transdermal Products
  • Transdermal Patches
  • Transdermal Gels
    • Ocular Drug Delivery
  • Liquid Formulations
  • Eye Drops
  • Liquid Sprays
  • Semi-Solid Formulations
  • Gels
  • Eye Ointments
  • Ocular Devices
  • Drug-Coated Contact Lenses
  • Ocular Inserts
    • Pulmonary Drug Delivery
  • Metered-Dose Inhalers
  • Dry Powder Inhalers
  • Nebulizers
  • Jet Nebulizers
  • Ultrasonic Nebulizers
  • Soft Mist Nebulizers
    • Nasal Drug Delivery
  • Nasal Drops
  • Nasal Sprays
  • Nasal Powders
  • Nasal Gels
    • Transmucosal Drug Delivery
  • Oral Formulations
  • Buccal Drug Delivery
  • Sublingual Drug Delivery
  • Others
  • Rectal Transmucosal Drug Delivery
  • Vaginal Transmucosal Drug Delivery
    • Implantable Drug Delivery
  • Active Implantable Drug Delivery
  • Passive Implantable Drug Delivery
  • By Patient Care Setting
    • Hospitals
    • Diagnostic Centers
    • Ambulatory Surgery Centers/Clinics
    • Home Care Settings
    • Others
  • By Application
    • Cancer
    • Infectious Diseases
    • Respiratory Diseases
    • Diabetes
    • Cardiovascular Diseases
    • Autoimmune Diseases
    • Central Nervous System Disorders
    • Others
  • Endocrine Disorders
  • Ophthalmic Disorders
  • By Geography
    • North America
  • Canada
  • Mexico
    • South America
  • Brazil
  • Argentina
  • Rest of South America
    • Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Turkey
  • Belgium
  • Netherlands
  • Switzerland
  • Rest of Europe
    • Asia-Pacific
  • Japan
  • China
  • South Korea
  • India
  • Australia
  • Singapore
  • Thailand
  • Malaysia
  • Indonesia
  • Philippines
  • Rest of Asia Pacific
    • Middle East & Africa
  • South Africa
  • Egypt
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Rest of Middle East & Africa

Key Developments in the Market:

  • In September 2018, Sulzer Ltd announced that they had completed the acquisition of MEDMIX SYSTEMS AG. This acquisition will help Sulzer Ltd in expanding their business segments to include the healthcare division and help in providing various products for the healthcare market.
  • In July 2018, Gerresheimer AG announced that they had acquired Sensile Medical and has expanded their service portfolios through this acquisition. This acquisition will help in expanding the technological portfolio of Gerresheimer AG due to Sensile’s expertise in the development and usage of liquid drug delivery devices.

 Reasons to Purchase this Report:

  • Current and future of global drug delivery devices market outlook in the developed and emerging markets
  • The segment that is expected to dominate the market as well as the segment which holds highest CAGR in the forecast period
  • Regions/Countries that are expected to witness the fastest growth rates during the forecast period
  • The latest developments, market shares, and strategies that are employed by the major market players

Customization of the Report:

  • All segmentation provided above in this report is represented at country level
  • All products covered in the market, product volume and average selling prices will be included as customizable options which may incur no or minimal additional cost (depends on customization)

 Want Full Report? Enquire Here:

About Us

Data Bridge set forth itself as an unconventional and neoteric Market research and consulting firm with an unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.

Data Bridge adepts in creating satisfied clients who reckon upon our services and rely on our hard work with certitude. Get Customization and Discount on Report by emailing . We are content with our glorious 99.9 % client satisfying rate.

Contact Us

Data Bridge Market Research
Toll Free: +1-888-387-2818


Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *